Exchange Auditorium: New treatments and measuring their impact

Back

Exchange Auditorium: New treatments and measuring their impact

11.25
CDK4/6i       
Professor Nicholas Turner

11.45
New Selective Oestrogen Receptor Downregulators   
Dr Lesley-Ann Martin

12.05
Liquid biopsies
Professor Jacqui Shaw

12.25
Selected Free Communication:
Finding determinants of PARP inhibitor sensitivity using genome-wide and focused CRISPR screens
Dr Stephen Pettitt, Institute of Cancer Research, London

Chairs: Dr Julia Gee & Professor Adrian Harris